advertisement

Topcon

Schweitzer JA 8

Showing records 1 to 8 | Display all abstracts from Schweitzer JA

89958 Corneal Hysteresis as a Biomarker of Glaucoma: Current Insights
Zimprich L
Clinical Ophthalmology 2020; 14: 2255-2264
90855 Prospective Interventional Cohort Study of Ocular Surface Disease Changes in Eyes After Trabecular Micro-Bypass Stent(s) Implantation (iStent or iStent inject) with Phacoemulsification
Schweitzer JA; Hauser WH
Ophthalmology and therapy 2020; 9: 941-953
89958 Corneal Hysteresis as a Biomarker of Glaucoma: Current Insights
Diedrich J; Bleeker A; Bleeker A
Clinical Ophthalmology 2020; 14: 2255-2264
90855 Prospective Interventional Cohort Study of Ocular Surface Disease Changes in Eyes After Trabecular Micro-Bypass Stent(s) Implantation (iStent or iStent inject) with Phacoemulsification
Ibach M
Ophthalmology and therapy 2020; 9: 941-953
89958 Corneal Hysteresis as a Biomarker of Glaucoma: Current Insights
Bleeker A
Clinical Ophthalmology 2020; 14: 2255-2264
90855 Prospective Interventional Cohort Study of Ocular Surface Disease Changes in Eyes After Trabecular Micro-Bypass Stent(s) Implantation (iStent or iStent inject) with Phacoemulsification
Baartman B
Ophthalmology and therapy 2020; 9: 941-953
89958 Corneal Hysteresis as a Biomarker of Glaucoma: Current Insights
Schweitzer JA
Clinical Ophthalmology 2020; 14: 2255-2264
90855 Prospective Interventional Cohort Study of Ocular Surface Disease Changes in Eyes After Trabecular Micro-Bypass Stent(s) Implantation (iStent or iStent inject) with Phacoemulsification
Gollamudi SR; Crothers AW; Linn JE; Berdahl JP
Ophthalmology and therapy 2020; 9: 941-953

Issue 21-3

Change Issue


advertisement

Oculus